Fingolimod Capsule
Product Images NDC 46708-228

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 46708-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Capsules (Fingolimod 05 mg)

Fingolimod Capsules 0.5 mg oral dosage form packaging label. The label indicates 30 capsules per package, manufactured by Alembic Pharmaceuticals Limited. It includes storage instructions and dosage reference, with a barcode and NDC 46708-228-30 clearly shown.*

FDA Label Image

Figure 1 (Fingolimod Fig1)

A line graph comparing the percentage of patients with three-month confirmed progression over time (days) between two treatment groups: Fingolimod 0.5 mg and placebo. The graph shows the progression percentage increasing over approximately 720 days, with placebo group reaching 24% and Fingolimod group 18%. The X-axis represents time in days, and the Y-axis shows the percentage of patients with confirmed progression.*

FDA Label Image

Structure (Fingolimod Str)

Chemical structure diagram of the active ingredient Fingolimod, showing its molecular arrangement including a phenyl ring, hydroxy groups, an amino group, and a chloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.